SCHEMBL20211

SCHEMBL20211

CNS(N)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethane SCHEMBL9044715 0.96
Methane SCHEMBL9047974 0.96
Hydrochloric Acid SCHEMBL12469062 0.96
SCHEMBL10408062 0.89 CA1 (0.39)
SCHEMBL10408061 0.83 CA1 (0.35)
Ethylamine SCHEMBL1871241 0.83 CA1 (0.40)
SCHEMBL3523807 0.75 CA1 (0.35)
SCHEMBL29195607 0.75
Sulfamide SCHEMBL28889919 0.73
SCHEMBL7205598 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1572 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240409556-A1 BENZOPIPERAZINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. 2024-12-12 US claimed
US-20240262801-A1 COMPOUNDS HAVING 5-(2-FLUORO-6-HYDROXYPHENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE AS INHIBITORS OF PROTEIN KINASE PHOSPHATASE ENZYMES MONDEGO BIO, LDA. (PT) 2024-08-08 US claimed
US-11708344-B2 Flavone derivatives for the treatment and prophylaxis of hepatitis B virus disease HOFFMANN-LA ROCHE INC. (US) 2023-07-25 US claimed
WO-2023087632-A1 ANTI-INFLAMMATORY ANALGESIC COMPOUND AND USE THEREOF 江苏新元素医药科技有限公司 2023-05-25 WO claimed
US-20230074887-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE HOFFMANN-LA ROCHE INC. (US) 2023-03-09 US claimed
CN-115078587-A SEM source analysis method in animal source aquatic product based on nitrogen isotope GC-IRMS analysis 浙江树人学院 2022-09-20 CN claimed
WO-2022164249-A1 NOVEL BENZOTRIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE, AND USE THEREOF 주식회사 티씨노바이오사이언스 2022-08-04 WO claimed
CN-114656429-A Anti-inflammatory analgesic compound and application thereof 江苏新元素医药科技有限公司 2022-06-24 CN claimed
EP-3860984-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. Hoffmann-La Roche AG (CH) 2021-08-11 EP claimed
CN-112912371-A Flavone derivatives for treating and preventing hepatitis B virus diseases 豪夫迈·罗氏有限公司 2021-06-04 CN claimed
EP-0983260-A2 3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. Searle & Co. (US) 2000-03-08 EP claimed
US-5990101-A Carbapenem derivatives MEIJI SEIKA KABUSHIKI KAISHA (JP) 1999-11-23 US claimed
US-5932576-A USEFUL FOR TREATING P38 KINASE MEDIATED DISORDERS SUCH AS ATHEROSCLEROSIS, RHEUMATIOD ARTHRITIS, INFLAMMATORY BOWEL DISEASE, PSORIASIS AND OTHERS G. D. SEARLE & COMPANY (US) 1999-08-03 US claimed
EP-0885186-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1998-12-23 EP claimed
WO-1998052937-A2 4-ARYL-3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS P38 KINASE G.D. SEARLE AND CO. (US) 1998-11-26 WO claimed
WO-1997019911-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1997-06-05 WO claimed
EP-0760370-A1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KABUSHIKI KAISHA (JP) 1997-03-05 EP claimed
US-5006170-A Thermal ink jet printing, binders, propellants XEROX CORPORATION (US) 1991-04-09 US claimed
US-4956163-A REACTING A PYROPHOSPHATE ION AND A SULFAMIDE MONSANTO COMPANY (US) 1990-09-11 US claimed
EP-0014476-B1 OPTICALLY ACTIVE ACYLATED CEPHALOSPORIN ANALOGS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM KYOWA HAKKO KOGYO CO., LTD (JP) 1983-08-10 EP claimed